Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Morgan Stanley

Galmed Pharmaceuticals Ltd.
Start price
€6.40
02.12.25 / 50%
Target price
-
02.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 02.12.26. The prediction end date can be changed by Morgan_Stanley at any time.
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. - -
iShares Core DAX® -0.121% 2.507%
iShares Nasdaq 100 0.081% -0.241%
iShares Nikkei 225® -1.748% 4.105%
iShares S&P 500 -0.961% -0.143%

Comments by Morgan_Stanley for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren

Globus Medical (NYSE:GMED) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for GMED provided by MarketBeat

Morgan Stanley 
0
Report Share
02.12.25 Buy -

Stopped prediction by Morgan_Stanley for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
15.07.25
€58.28
15.07.26
-
19.09.24

Morgan Stanley 
15.07.25 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
02.12.24
€95.17
02.12.25
-
03.12.25

Morgan Stanley 
02.12.24 50%